These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 9085197
1. The dose-response characteristics of rat oral dyskinesias with chronic haloperidol or clozapine administration. Gao XM, Hashimoto T, Cooper TB, Tamminga CA. J Neural Transm (Vienna); 1997; 104(1):97-104. PubMed ID: 9085197 [Abstract] [Full Text] [Related]
2. Comparison of chronic administration of haloperidol and the atypical neuroleptics, clozapine and raclopride, in an animal model of tardive dyskinesia. See RE, Ellison G. Eur J Pharmacol; 1990 Jun 08; 181(3):175-86. PubMed ID: 2384130 [Abstract] [Full Text] [Related]
3. Chronic oral haloperidol and clozapine in rats: A behavioral evaluation. Schmitt U, Dahmen N, Fischer V, Weigmann H, Rao ML, Reuss S, Hiemke C. Neuropsychobiology; 1999 Jun 08; 39(2):86-91. PubMed ID: 10072665 [Abstract] [Full Text] [Related]
4. Clozapine in tardive dyskinesia: observations from human and animal model studies. Tamminga CA, Thaker GK, Moran M, Kakigi T, Gao XM. J Clin Psychiatry; 1994 Sep 08; 55 Suppl B():102-6. PubMed ID: 7961550 [Abstract] [Full Text] [Related]
5. Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia. Bishnoi M, Kumar A, Chopra K, Kulkarni SK. Indian J Exp Biol; 2007 Feb 08; 45(2):175-9. PubMed ID: 17375557 [Abstract] [Full Text] [Related]
8. Chronic olanzapine or sertindole treatment results in reduced oral chewing movements in rats compared to haloperidol. Gao XM, Sakai K, Tamminga CA. Neuropsychopharmacology; 1998 Nov 08; 19(5):428-33. PubMed ID: 9778664 [Abstract] [Full Text] [Related]
9. Drug-induced oral dyskinesias in rats after traditional and new neuroleptics. Kakigi T, Gao XM, Tamminga CA. J Neural Transm Gen Sect; 1995 Nov 08; 101(1-3):41-9. PubMed ID: 8695056 [Abstract] [Full Text] [Related]
10. Novel oral drug administration in an animal model of neuroleptic therapy. Schleimer SB, Johnston GA, Henderson JM. J Neurosci Methods; 2005 Aug 15; 146(2):159-64. PubMed ID: 16054505 [Abstract] [Full Text] [Related]
11. Quantitative light microscopic demonstration of increased pallidal and striatal met5-enkephalin-like immunoreactivity in rats following chronic treatment with haloperidol but not with clozapine: implications for the pathogenesis of neuroleptic-induced movement disorders. Auchus AP, Pickel VM. Exp Neurol; 1992 Jul 15; 117(1):17-27. PubMed ID: 1618284 [Abstract] [Full Text] [Related]
17. Effects of chronic haloperidol and clozapine on vacuous chewing and dopamine-mediated jaw movements in rats: evaluation of a revised animal model of tardive dyskinesia. Ikeda H, Adachi K, Hasegawa M, Sato M, Hirose N, Koshikawa N, Cools AR. J Neural Transm (Vienna); 1999 Sep 12; 106(11-12):1205-16. PubMed ID: 10651114 [Abstract] [Full Text] [Related]